Portola Pharmaceuticals News - PTLA

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Portola Pharmaceuticals Inc PTLA NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.86 3.03% 29.21 29.24 28.45 28.63 28.35 00:00:02
more quote information »

Recent News

Date Time Source Heading
11/21/201917:08EDGARCurrent Report Filing (8-k)
11/15/201916:25PRNUSAndexxa Highlighted as a First-Line Factor Xa Reversal..
11/06/201910:07PRNUSPortola Pharmaceuticals to Present Multiple Abstracts at the..
11/05/201917:12EDGARQuarterly Report (10-q)
11/05/201916:14EDGARCurrent Report Filing (8-k)
11/05/201916:00PRNUSPortola Pharmaceuticals Reports Third Quarter 2019 Financial..
11/01/201916:30PRNUSPortola Pharmaceuticals Reports Inducement Grants Under..
10/28/201909:00PRNUSPortola Pharmaceuticals Presents New Analysis from the..
10/15/201908:30PRNUSPortola Pharmaceuticals to Announce Third Quarter 2019..
10/02/201916:21EDGARStatement of Changes in Beneficial Ownership (4)
10/02/201916:17EDGARInitial Statement of Beneficial Ownership (3)
9/23/201906:33EDGARCurrent Report Filing (8-k)
9/19/201908:20PRNUSPortola Pharmaceuticals Appoints Ted W. Love, M.D., to its..
9/05/201919:06EDGARStatement of Changes in Beneficial Ownership (4)
9/05/201919:03EDGARStatement of Changes in Beneficial Ownership (4)
9/03/201918:05EDGARStatement of Changes in Beneficial Ownership (4)
8/22/201908:30PRNUSPortola Pharmaceuticals to Participate in Two Upcoming..
8/14/201916:20EDGARCurrent Report Filing (8-k)
8/14/201916:15EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
8/13/201919:32PRNUSPortola Pharmaceuticals Announces Pricing of Public Offering..
8/12/201916:46EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
8/12/201916:43PRNUSPortola Pharmaceuticals Announces Proposed Offering of..
8/09/201918:51EDGARStatement of Changes in Beneficial Ownership (4)
8/07/201917:16EDGARSecurities Registration: Employee Benefit Plan (s-8)
8/07/201917:12EDGARAutomatic Shelf Registration Statement of Securities of..
8/07/201916:32EDGARQuarterly Report (10-q)
8/07/201916:13EDGARCurrent Report Filing (8-k)
8/07/201916:05PRNUSPortola Pharmaceuticals Reports Second Quarter 2019..
8/06/201908:30PRNUSPortola Launches European Sales of Ondexxya® (Andexanet..
8/05/201907:00PRNUSU.S. Centers for Medicare and Medicaid Services (CMS)..
7/17/201908:30PRNUSPortola Pharmaceuticals to Announce Second Quarter 2019..
7/08/201908:30PRNUSPortola Pharmaceuticals Presents New In Vitro Data..
6/19/201911:05PRNUSPortola Presents New Interim Data on its Oral SYK/JAK..
6/17/201917:43EDGARStatement of Changes in Beneficial Ownership (4)
6/17/201917:37EDGARStatement of Changes in Beneficial Ownership (4)
6/17/201917:34EDGARStatement of Changes in Beneficial Ownership (4)
6/17/201917:27EDGARStatement of Changes in Beneficial Ownership (4)
6/17/201917:20EDGARStatement of Changes in Beneficial Ownership (4)
6/17/201917:16EDGARStatement of Changes in Beneficial Ownership (4)
6/14/201916:49EDGARCurrent Report Filing (8-k)
6/05/201917:07EDGARStatement of Changes in Beneficial Ownership (4)
5/28/201916:30GLOBEPortola Pharmaceuticals to Participate in Two Upcoming..
5/22/201910:45GLOBEPortola Pharmaceuticals Announces New Analysis from the..
5/08/201908:38EDGARQuarterly Report (10-q)
5/08/201908:07EDGARCurrent Report Filing (8-k)
5/08/201908:01GLOBEPortola Pharmaceuticals Reports First Quarter 2019 Financial..
4/26/201914:00GLOBEEuropean Commission Grants Conditional Marketing..
4/25/201911:21EDGARCurrent Report Filing (8-k)
4/24/201908:30GLOBEPortola Pharmaceuticals Announces Retirement of Dr. John..
4/22/201906:03EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
See more news about this stock »

Your Recent History
Portola Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.